Sign In
Buy AERI
$15.25
+0 (+0%)
At Close: Feb 17, 2023
Aerie Pharmaceuticals (AERI) Expected to Beat Earnings Estimates: Should You Buy?
12:00am, Tuesday, 28'th Apr 2020Mizuho Securities Thinks Aerie Pharma's Stock is Going to Recover
12:33pm, Friday, 24'th Apr 2020
Mizuho Securities analyst Difei Yang maintained a Buy rating on Aerie Pharma (AERI) today and set a price target of $34.00. The company's shares closed
Mizuho Securities Thinks Aerie Pharma’s Stock is Going to Recover
12:33pm, Friday, 24'th Apr 2020
Mizuho Securities analyst Difei Yang maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a
Needham Thinks Aerie Pharma's Stock is Going to Recover
12:18pm, Friday, 24'th Apr 2020
Needham analyst Serge Belanger assigned a Buy rating to Aerie Pharma (AERI) today and set a price target of $40.00. The company's shares closed last
Needham Thinks Aerie Pharma’s Stock is Going to Recover
12:17pm, Friday, 24'th Apr 2020
Needham analyst
Serge Belanger
assigned a
Buy
rating to Aerie Pharma (
AERI
–
Research Report
) today and set a price target of
$40.00
. The company’s shares closed last Thursday at $14.01, close
Frontier Capital Management Co. LLC Decreases Position in Aerie Pharmaceuticals Inc (NASDAQ:AERI)
09:34am, Monday, 20'th Apr 2020
Frontier Capital Management Co. LLC lowered its stake in shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 22.7% in the 1st quarter, HoldingsChannel reports. The firm owned 420,539 shares of the co
Aerie Pharmaceuticals Inc (NASDAQ:AERI) Sees Large Decrease in Short Interest
07:04am, Monday, 20'th Apr 2020
Aerie Pharmaceuticals Inc (NASDAQ:AERI) was the target of a significant drop in short interest in the month of March. As of March 31st, there was short interest totalling 9,250,000 shares, a drop of 2
Q1 2020 EPS Estimates for Aerie Pharmaceuticals Inc (NASDAQ:AERI) Boosted by Oppenheimer
06:28am, Saturday, 18'th Apr 2020
Aerie Pharmaceuticals Inc (NASDAQ:AERI) – Analysts at Oppenheimer lifted their Q1 2020 EPS estimates for shares of Aerie Pharmaceuticals in a report issued on Monday, April 13th. Oppenheimer analyst
Mizuho Securities Thinks Aerie Pharma's Stock is Going to Recover
12:35pm, Friday, 17'th Apr 2020
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Aerie Pharma (AERI), with a price target of $34.00. The company's
Mizuho Securities Thinks Aerie Pharma’s Stock is Going to Recover
12:35pm, Friday, 17'th Apr 2020
In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Aerie Pharma (AERI – Research
This is what access to clean water looks like for a First Nation in a remote corner of Ontario
12:00am, Friday, 17'th Apr 2020
With a lack of infrastructure, funding, treatment plants and even roads, the struggle for drinking water seems never-ending.
Goldman Sachs Group Inc. Has $2.21 Million Stock Holdings in Aerie Pharmaceuticals Inc (NASDAQ:AERI)
08:38am, Tuesday, 14'th Apr 2020
Goldman Sachs Group Inc. cut its position in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 79.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owne
Aerie Pharmaceuticals (NASDAQ:AERI) Given New $34.00 Price Target at Mizuho
07:25am, Tuesday, 14'th Apr 2020
Aerie Pharmaceuticals (NASDAQ:AERI) had its price objective reduced by Mizuho from $54.00 to $34.00 in a research report sent to investors on Monday, The Fly reports. They currently have a buy rating
Aerie (AERI) Suspends Guidance Due to Coronavirus Outbreak
02:01pm, Monday, 13'th Apr 2020
Aerie (AERI) suspends annual guidance as volumes get impacted due to the COVID-19 outbreak.
Aerie (AERI) Suspends Guidance Due to Coronavirus Outbreak
02:01pm, Monday, 13'th Apr 2020
Aerie (AERI) suspends annual guidance as volumes get impacted due to the COVID-19 outbreak.
